Company Data
Tarsus Pharmaceuticals Inc.
Ticker
TARS
Current Price
$74.9 -1.71%
Market Cap
$3.2B
Price Target
Refer to Report
Volume
319.2K
52wk Range
$38.51 - $85.25
Overview
Tarsus Pharmaceuticals Inc is a late clinical-stage biopharmaceutical company. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company’s lead candidate TP-03, is a novel drug that targets the Demodex mite nervous system to kill the mites.